The inaacellular localization in rat bronchiolar epithelial ells of a novel trypsin-like protease named tryptase Clara, a possible activator of inactive viral fusion glycoprotein of influenza A and wild-type Sendai virus in the respiratory tract, was examined by electron microscopy. In thin sections embedded in LR White, gold particles indicating immunoreactivity of tryptase Clara were detected specifically in secretory granules of Clara cells. No immunoreactivity was detected in bronchiolar ciliated cells, alveolar cells including epithelial Type I and I1 cells, or alveolar maaophages. Some granules enveloped in a thin membrane and labeled intensely with immunogold particles were seen protruding
Introduction
Post-translational proteolytic cleavage of the fusion glycoprotein (F) of paramyxoviruses, such as Sendai virus and Newcastle disease virus, and of the hemagglutinin (HA) of influenza viruses, is required for their infectivity and determines the pathogenicity of these viruses (1-3). The F and HA proteins are cleaved only by specific proteases, such as trypsin (3,4) in vitro, clotting factor Xa in the allantoic fluid of chick embryos (5,6), and unidentified argininespecific serine protease(s) in the respiratory tract (7-9). These envelope glycoproteins are not cleaved by a ubiquitous host protease(s) present in various cell types (10). The protease(s) in the respiratory tract has been postulated to be a primary determinant of the pneumotropism and pathogenicity of these viruses (7, 8) , but at present little is known about its characteristics.
Recently we isolated a novel trypsin-type serine protease from rat lung that cleaves HA of influenza virus (11) and F of Sendai virus (Tashiro This is the first observation of the processing protease in the respiratory tract. The enzyme, named tryptase Clara, differs in enzymatic properties from the serine proteases in various cells and is localized exclusively in non-ciliated secretory cells, Clara cells, of the bronchial and bronchiolar epithelium (11), as shown by immunoperoxidase histochemical staining at the light microscopic level.
In this article we report the intracellular localization of the enzyme in rat bronchiolar epithelial Clara cells, which are the typical cells with tryptase Clara in the respiratory tract, as determined by immunoelectron microscopy, and we discuss the possible site of processing of progeny enveloped pneumotropic viruses in vivo.
Materials and Methods
Animals. Male Wistar strain rats Uapan SLC; Shizuoka, Japan) weighing 160-180 g were used.
Materials. Tryptase Clva was purified from rat lung by standard chromatographic procedures and antiserum against the enzyme was prepared by injecting the purified preparation into New Zealand White rabbits (Japan SLC) as reported previously (11) . Antigen-affinity-purified IgG was obtained by chromatography on a column of purified enzyme coupled with Sepharose 4B (Pharmacia LKB Biotechnology; Uppsala, Sweden).
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Elecnon Immunohistochcmimg. Animals were anenhetized by IP injection of sodium pentobarbital and 200 U of heparin in 0.2 ml of d i n e were injected into the inferior vena cava. Then aannulawas inserred through the inferior vena cava to the right atrium. and ligated in place as described previously (1 1). The lungs were perfused through the cannula with Ca2'and M e -f n r Dulbecco's phosphate-buffered saline (Gibco; Grand Island, NY) until the perfusate was free of blood. Then the lungs were fixed by instillation into the trachea and perfusion of the lung with freshly prepared 4% paraformaldehyde-0.5 % glutaraldehyde buffered with 0.1 M sodium cacodylate, pH 7.2. for 10 min. The lungs were then excised and fixed in the same fixative for 2 hr at 4'C. The fixed lungs were cut into small pieces. which were thoroughly washed with the m e buffercontaining 8% sucrox. dehydrated in a graded ethanol series, and embedded in LR White acrylic resin (London Resin; London. UK). Thin sections were cut with an ultramicrotome and mounted on nickel grids (200 mesh). The grids loaded with ultra-thin sections were washed with 0.01 M phosphate buffer. pH 7.2. containing 0.5 M NaCl (PB) and floated on a droplet of 3% bovine serum albumin (BSA) in PB for 15 min. They were then transferred to a droplet of affinity-purified antibody (60 pglml) against tryptase Clara in PB containing 0.1% BSA and kept overnight at 4'C. The grids were washed with PB and incubated with protein A-colloidal gold panicles (20 nm diameter) (EY Labs; San Mateo, CA) dissolved in PB containing 0.1 % BSA for 4 hr at room temperature. After immunomcrions. sections were washed with PB, stained with a saturated aqueous solution of uranyl acemte and l a d citrate and observed with a Hitachi HU-12 clectron microscope at 75 kV.
Control Experiments. Thin Kctions were incubated with non-immune rabbit IgG (60 pglml). followed by gold particle-labeled protein A. Some sections were incubated directly with gold without pre-treatment with the fint antibody.
Rats wtre anestherizcd and 6 ml of fmhly prepared 2% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4. was instilled into the lungs via a tracheal cannula for 20 min. The lungs were then excised. sliced at about 3-mm thickness. and fixed in the m e fixative for 2 hr at 4'C. Preparations were dehydrated with increasing concentrations ofethanol for 30 min a c h , dried in a critical-point Hitachi HCP-2 apparatus under COz. and coated with gold. The specimens were examined in a Hitachi s-800 field emission scanning elervon microscope at 25 kV. E l and U " Immunobl&g.
Lungs were homogenized in 10 volumes of 50 mM Tris-HCI. pH 6.8. containing 0.5% Nonidet P-40, 50 pM chymostatin. 20 pM leupeptin. 100 pM E-64, and 100 pM benzamidine in a Polytron homogenizer (Kinematica; Lucerne. Switzerland) for 15 sec at 0%. The homogenate was centrifuged at 25.000 x g for 20 min. and the multing supernatant was analyzed by electrophoresis in 10-20% gradient polyacrylamide gel containing 0.1% SDS by the method of kemmli (12) under reducing conditions. The gel was stained for protein with Coomassic Brilliant Blue R-250. SDS-polyacrylamide low-range standards (Bio-Rad; Richmond, CA) were used as molecular weight mark-CIS. For Western blot analysis. the enzyme preparations were subjected to electrophoresis in SDS-PAGE and transferred electrophoretically to an Immobilon transfer membrane (Millipore; Tokyo, Japan). The membrane was d e d in 1% BSA to block nonspecific binding, then incubated for 15 hr at room temperature with 1:lOOO dilution of affinity-purified antibody (1.24 mglml) for the purified enzyme. Bound antibody was detected by the anti-alkaline phosphatase method (Stratagene. LaJolla. CA) according to the manufacturer's instructions.
Results

Characterktics of Anhgen and Anti&ody
Purified tryptase Clara from rat lung had an apparent molecular mass of 30 KD on SDS-PAGE under reducing conditions, as shown in Figure 1 (Lane 2) . On Westem blot analysis of a lung homogenate, affinity-purified antibody against uyptase Clara stained a band of 30 KD strongly and a band of 28.5 KD slightly (Lane 3). The latter minor immunoreactive band may be that of a derivative of the 30 KD protein (11).
Immunoelectron Microscopy
In thin sections of samples embedded in LR White, gold particles indicating the antigenic site of tryptase Clara were mainly deposited in secretory granules of non-ciliated epithelial Clara cells in bronchioles of the lung (Figure 2A ). There were a few immunoreactive gold particles in the cytosol in addition to those in the granules of Clara cells. Neither the nucleus nor the mitochondria of the cells showed specific reactivity with the enzyme. Some granules labeled with gold particles protruded from the cell surface (Figure 2B) . In addition, a few coated granules labeled with gold particles were found free in the bronchiolar lumen, as verified by serial sectioning (Figure 2C) tryptase Clara are secreted into the bronchiolar lumen. This possibility is consistent with a previous finding of immunoreactive proteins in the cell-free airway lavage fluid by Western blot analysis (11), which may be secreted from the vacuoles. Control thin sections incubated with non-immune rabbit IgG instead of the first antibody showed no specific deposits of gold particles ( Figure 2D) .
No immunoreactivity of tryptase Clara was detected in ciliated epithelial cells of terminal bronchioles, alveolar Type I cells, alveolar Type I1 cells, and alveolar macrophages (data not shown).
Scanning Electron Microscopy
The luminal surface of terminal bronchioles was observed by scanning electron microscopy (Figure 3) . Individual non-ciliated Clara cells were surrounded by cilia of several ciliated cells. The surface of the cells had several smooth droplets, ranging in size from 200-600 nm, along the main body. These droplets may correspond to the granules with tryptase Clara protruded from the cell surface ( Figure 2B) and those in the bronchiolar lumen ( Figure 2C ).
Discussion
We recently purified a new trypsin-like protease to homogeneity from rat lung and named the enzyme "Tryptase Clara" because of its constant localization in non-ciliated secretory epithelial Clara cells in the respiratory tract but not in other types of epithelial cells in the respiratory tract and lung cells, as shown immunohistochemically by light microscopy (11). The present study demonstrated the subcellular distribution of the enzyme immunohistochemically by electron microscopy. The results showed that Clara cells have secretory granules in their cytosol, with a variety of densities of immunoreactivity. Some secretory granules labeled with gold particles protruded from the plasma membrane or from submembrane fractions of Clara cells. Moreover, immunoreactive granules enveloped in a thin cytoplasmic coat were occasionally seen free in the airway. These observations suggest that the enzyme is released into the bronchiolar lumen physiologically. This suggestion is supported by scanning electron microscopic demonstration of smooth droplets on the cell surface and by Western blotting analysis, which indicated the presence of immunoreactive protein in cell-free airway lavage fluid (11).
Recently, Clara cells have been reported to be a source of pulmonary surfactant together with alveolar Type I1 cells of the alveolar space (13-15). Clara cells have also been shown to have characteristic proteins in their secretory granules, such as specific 10 KD protein (16, 17) , bgalactoside-binding lectin (18) , and some unidentified proteins (19) . However, the physiological roles of Clara cells and of the proteins such as tryptase Clara in the secretory granules in respiratory functions are unclear.
Proteolytic cleavages of HA glycoprotein of influenza viruses and F glycoproteins of paramyxoviruses are known to be prerequisites for penetration of these viruses into cells (20-22). Limited cleavage of HA and F of these viruses is accomplished by a trypsin-like protease(s) in host cells, resulting in fully infectious virus. Mouse bronchiolar epithelium and human respiratory secretions have been shown to have a protease(s) that efficiently cleaves and activates Sendai virus Fo (1,3) and influenza A virus HA glycoproteins (9), respectively, although the sources of these proteases have not been identified. In a previous study we found that tryptase Clara purified from rat lung activated infectivity of influenza A virus (11) and Sendai virus (Tashiro M et al, submitted for publication) dosedependently in vitro. Extracellular administration of antibody against tryptase Clara almost completely inhibited Sendai virus activation in vitro and in lung block cultures (Tashiro M et al. submitted for publication). In addition, when the antibody was administered intranasally and intraperitoneally to rats infected with Sendai virus, activation of the progeny virus in the lung was reduced to 10-20% and viral replication was suppressed accordingly (Tashiro M et al., submitted for publication). These results indicate that tryptase Clara is a major activating protease for Sendai virus in rat lungs and that it activates the progeny virus extracellularly in the airway lumen. Furthermore, intranasal infection of rats with Sendai virus was observed to stimulate secretion of tryptase Clara two-to threefold after inoculation for 12 hr, resulting in a condition preferable for viral activation and multiplication in the bronchial lumen in vitro (Kido et al., manuscript in preparation). These results support our hypothesis that tryptase Clara, in cytoplasmic vacuoles of Clara cells is secreted into the bronchiolar lumen, then from vacuoles into the lavage, and is then able to activate the progeny of pneumotropic viruses, such as Sendai virus and influenza viruses.
Further studies are needed to investigate the precise mechanism of activation of these viruses by tryptase Clara. 
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